What Researchers Did
Researchers conducted a randomized, sham-controlled, double-blind trial with 73 post-COVID-19 patients to assess the effects of hyperbaric oxygen therapy on brain connectivity, cognition, and psychological distress.
What They Found
The hyperbaric oxygen therapy group showed decreased internetwork connectivity, which negatively correlated with improvements in attention and executive function scores (p < 0.001). Significant group-by-time interactions were observed in right hippocampal resting state functional connectivity (PFWE = 0.002), and negative correlations were found between psychological distress scores and specific brain connectivity measures (PFWE = 0.012, 0.002).
What This Means for Canadian Patients
For Canadian patients experiencing persistent neurocognitive symptoms after COVID-19, hyperbaric oxygen therapy may offer a potential avenue for improving brain connectivity and cognitive function. However, more research is required to establish its routine clinical use and accessibility within the Canadian healthcare system.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The abstract does not explicitly detail study limitations, but the generalizability of these findings to broader populations and long-term efficacy require further investigation.